New drug combo shows promise for Hard-to-Treat uterine cancer
Disease control
Ongoing
This study tests a combination of two drugs, alpelisib and fulvestrant, in people with a specific type of advanced uterine cancer (endometrioid endometrial cancer) that has a PIK3CA gene mutation. The goal is to see if the treatment can shrink or control the cancer. About 51 part…
Phase: PHASE2 • Sponsor: GOG Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC